CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomics and personalized medicine.
083790 | KO
Overview
Corporate Details
- ISIN(s):
- KR7083790006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
- Website:
- https://cginvites.com/en
- Sector:
- Manufacturing
Description
CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-05-26 00:00 |
투자판단관련주요경영사항(코로나19 바이러스(SARS-CoV-2) 감염이 확진된 COVID-19환자에서 Camostat의 유효성 및 안전성을 평…
|
Korean | 11.4 KB | ||
| 2020-05-22 00:00 |
기업설명회(IR)개최
|
Korean | 7.7 KB | ||
| 2020-05-15 00:00 |
분기보고서 (2020.03)
|
Korean | 2.2 MB | ||
| 2020-04-28 00:00 |
증권발행결과(자율공시)(제3자배정 유상증자)
|
Korean | 5.9 KB | ||
| 2020-04-21 00:00 |
투자판단관련주요경영사항(캄렐리주맙(Camrelizumab, PD-1항체 면역항암제)의 한국 독점 라이선스 도입 계약)
|
Korean | 12.0 KB | ||
| 2020-04-20 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 20.7 KB | ||
| 2020-04-03 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2020-04-03 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.5 KB | ||
| 2020-04-03 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 119.7 KB | ||
| 2020-03-30 00:00 |
사업보고서 (2019.12)
|
Korean | 2.7 MB | ||
| 2020-03-27 00:00 |
정기주주총회결과
|
Korean | 29.4 KB | ||
| 2020-03-27 00:00 |
주식매수선택권부여에관한신고
|
Korean | 13.9 KB | ||
| 2020-03-27 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 6.5 KB | ||
| 2020-03-27 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 6.6 KB | ||
| 2020-03-27 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 6.6 KB |
Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CG Invites Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
